SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (222)1/27/2001 8:16:22 PM
From: Scott H. Davis  Read Replies (1) of 370
 
And another option is if the science is solid, has significant market value, if they have advanced to PIII, they may be a much candidate for companies like MLNM what are looking to move beyond being an enabling technology company to a full bio-pharmaceutical, especially now that some of these have a lot of cash, with revenue streams from current licensings, and they are getting much better's deals with pharma's, or even bypassing by contracting out marketing. The last year has seen some new dynamics.

Just a thought, Scott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News